课题基金 / 基金详情

HUMAN RHEUMATOID FACTOR CROSS-IDIOTYPES

HUMAN RHEUMATOID FACTOR CROSS-IDIOTYPES
人类类风湿因子跨独特型
批准号:
3138333
负责人:
Vincent Agnello
金额:
$16.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-30 至 1990-08-31

项目摘要

项目成果

Vincent Agnello的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The occurrence of the three human monoclonal rheumatoid factor (mRF) cross idiotypes (XIds) WA, PO and BLA among polyclonal rheumatoid factors in various diseases and among immunogobulins in normals will be studied using mouse monoclonal antibodies with specifities for the heat labile conformational heavy-light chain XId antigens that are the main determinants recognized by the original polyclonal antisera which defined the mRF XIds. Occurrence of the mRF XIds in the B cell repertoire will also be accessed. The role of heavy and light chains in forming the XId antigens and in determining the antigen specificities of the mRFs of the three groups will be determined by assorted heavy-light chain recombinations. Studies on the PO XId will persue preliminary data which suggests that this XId determinant, in contrast to the WA and BLA XIds, is not associated with the antigen combining site. Special emphasis will be placed on study of the BLA XId which has been shown to occur in high incidence among polyclonal RFs in rheumatoid arthritis. The RFs bearing this XId have unique specificity in that they react with DNA- histone 2A-2B, antigen in addition to IgG. The amino acid sequence of the variable regions of the light and heavy chains of the prototype monoclonal and polyclonal RFs of this group will be determined in search of insights not only to the structural- idiotype-antigen specificity relationships but also restrictions that may be present in autoantibody production. The occurrence of various mRF complementary determining region (CDR) antigens on polyclonal rheumatoid factors, other polyclonal autoantibodies and normal immunoglobulins using antisera raised to synthetic CDR peptides will be determined to test the hypothesis that certain CDR antigens are selectively associated with autoantibodies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HEPATITIS C VIRUS IN ETIOLOGY OF WA RHEUMATOID FACTORS
  • 批准号:
    6373588
  • 项目类别:
  • 资助金额:
    $23.37万
  • 财政年份:
    1999
  • 负责人:
    Vincent Agnello
  • 依托单位:
HEPATITIS C VIRUS IN ETIOLOGY OF WA RHEUMATOID FACTORS
  • 批准号:
    2852893
  • 项目类别:
  • 资助金额:
    $23.02万
  • 财政年份:
    1999
  • 负责人:
    Vincent Agnello
  • 依托单位:
HEPATITIS C VIRUS IN ETIOLOGY OF WA RHEUMATOID FACTORS
  • 批准号:
    6169771
  • 项目类别:
  • 资助金额:
    $22.81万
  • 财政年份:
    1999
  • 负责人:
    Vincent Agnello
  • 依托单位:
HEPATITIS C VIRUS IN ETIOLOGY OF WA RHEUMATOID FACTORS
  • 批准号:
    6326307
  • 项目类别:
  • 资助金额:
    $9.03万
  • 财政年份:
    1999
  • 负责人:
    Vincent Agnello
  • 依托单位:
国内基金
海外基金
PCV2茎环结构DNA激活cGAS-STING通路诱导的天然免疫应答的作用研究
  • 批准号:
    2026JJ50413
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王东亮
  • 依托单位:
机械力响应型DNA探针用于肿瘤微环境细胞力学可视化与药物筛选研究
  • 批准号:
    2026JJ60135
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    杨思慧
  • 依托单位:
CDC45通过调控DNA复制应激促进肝癌发生发展的机制
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
  • 批准号:
    JCZRLH202601177
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: